Sh-polypeptide-1 is a growth-factor protein used in scalp products and professional hair-regrowth treatments. Controlled human studies support added benefit with minoxidil or blood-derived scalp injections; standalone cosmetic-serum effectiveness remains unresolved. Product identity, activity, and delivery matter. Injection reactions and procedure burden accompany uncertain long-term safety. Lasting results and maintenance needs remain unresolved; hair regrowth is distinct from an established health or longevity benefit. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Scalp hair density | No established target; hairs/cm² versus personal baseline | Quantify regrowth |
| Hair shaft diameter | No established target; change from baseline | Assess thickening |
| Scalp inflammation | No established numerical target; redness, pain, lesions versus baseline | Detect local harm |
| Ferritin, if deficiency is suspected | No sh-polypeptide-1-specific functional target; correction of confirmed deficiency | Assess another cause |
| Thyroid function, if clinically indicated | No peptide-specific functional target; track diagnosed thyroid disorder | Assess another cause |
Cadence: Baseline; tolerability at 2–4 weeks; photographs and counts at 3 and 6 months; new scalp symptoms as they occur. Illustrative documentation schedule, not a validated treatment protocol.